Die neuesten CRL Reports werden am 2024-02-14 aktualisiert: 2023 ∙ 2022 ∙ 2021

Charles River Laboratories International CRL

€ 215.54 1.56%

Andere Aktien der Branche "Diagnostik & Forschung"

Name	Preis	% 24h	Marktkapitalisierung	Börse	Land
PerkinElmer PKI	$ 115.24	-0.91 %	$ 14.7 B	NYSE,SPB	USA
Fluidigm Corporation FLDM	$ 3.75	1.08 %	$ 308 M	Nasdaq Global Select Market	USA
Global Cord Blood Corporation CO	$ 2.99	-	$ 399 M	NYSE	China
Oxford Immunotec Global PLC OXFD	$ 21.99	-	$ 562 M	Nasdaq Global Select Market	Britain
Medpace Holdings MEDP	$ 392.57	0.38 %	$ 12.1 B	Nasdaq Global Select Market,SPB	USA
Chembio Diagnostics CEMI	$ 0.46	0.22 %	$ 16.8 M	Nasdaq Capital Market	USA
Quidel Corporation QDEL	$ 42.5	0.66 %	$ 1.79 B	Nasdaq Global Select Market,SPB	USA
Meridian Bioscience VIVO	$ 33.97	-	$ 1.49 B	Nasdaq Global Select Market	USA
HTG Molecular Diagnostics HTGM	$ 0.48	-20.0 %	$ 1.06 M	Nasdaq Capital Market	USA
Quotient Limited QTNT	$ 0.32	-11.32 %	$ 1.1 M	Nasdaq Global Select Market	Schweiz
Personalis PSNL	$ 2.17	-14.57 %	$ 102 M	Nasdaq Global Select Market	USA
Co-Diagnostics CODX	$ 1.21	0.83 %	$ 35.5 M	Nasdaq Capital Market	USA
PRA Health Sciences, Inc. PRAH	$ 165.21	-	$ 10.7 B	Nasdaq Global Select Market	USA
Bioventus BVS	$ 3.97	0.25 %	$ 249 M	Nasdaq Global Select Market	USA
Castle Biosciences CSTL	$ 24.33	6.52 %	$ 652 M	Nasdaq Global Market,SPB	USA
DarioHealth Corp. DRIO	$ 1.57	3.29 %	$ 44.5 M	Nasdaq Capital Market	Israel
Heska Corporation HSKA	$ 119.99	-	$ 1.31 B	Nasdaq Capital Market,SPB	USA
Danaher Corporation DHR	$ 248.38	0.62 %	$ 183 B	NYSE,SPB	USA
Enzo Biochem ENZ	$ 1.04	-	$ 51.1 K	NYSE	USA
Agilent Technologies A	$ 139.45	1.4 %	$ 42.4 B	NYSE,SPB	USA